Im Focus Onkologie

, Volume 21, Issue 5, pp 72–77 | Cite as

S3-Leitlinie „Supportive Therapie bei onkologischen PatientInnen“

Supportive Maßnahmen in der Radioonkologie

Supportivtherapie Fortbildung
  • 4 Downloads

Unter einer Bestrahlung können akute, aber auch späte Nebenwirkungen auftreten. Einige lassen sich aber wirksam vermeiden oder gut behandeln. Dabei ist die interdisziplinäre Kommunikation entscheidend — vor, während und nach der Bestrahlung.

Literatur

  1. 1.
    S3-Leitlinie Supportive Therapie bei onkologischen PatientInnen. Langversion 1.0 — November 2016. AWMF-Registernummer: 032/054OL.Google Scholar
  2. 2.
    Kiliç D et al. Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of sulphasalazine in preventing acute gastrointestinal complications due to radiotherapy. Radiother Oncol. 2000;57(2):125–9.CrossRefGoogle Scholar
  3. 3.
    Westbury C et al. Advice on hair and scalp care during cranial radiotherapy: a prospective randomized trial. Radiother Oncol. 2000;54(2):109–16.CrossRefGoogle Scholar
  4. 4.
    Höller U et al. [Osteoradionecrosis after radiotherapy for gynecologic tumors]. Strahlenther Onkol. 2001;177(6):291–5.CrossRefGoogle Scholar
  5. 5.
    Heyboer M 3rd et al. Hyperbaric oxygen and dental extractions in irradiated patients: short- and long-term outcomes. Undersea Hyperb Med. 2013;40(3):283–8.PubMedGoogle Scholar
  6. 6.
    Grötz KA; Strahlenther Onkol. 2003 Apr;179(4):275-8. [Dental care for patients with antineoplastic radiotherapy of the head and neck]. [Article in German]. Grötz KA; Gemeinsame Stellungnahme der DGZMK und der DEGRO in Abstimmung mit dem Vorstand der DGZ. [Dental care for patients with antineoplastic radiotherapy of the head and neck]. Strahlenther Onkol. 2003;179(4):275–8.PubMedGoogle Scholar
  7. 7.
    McGuire DB et al. Systematic review of basic oral care for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(11):3165–77.CrossRefGoogle Scholar
  8. 8.
    Lalla RV et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014;120(10):1453–61.CrossRefGoogle Scholar
  9. 9.
    Horiot JC et al. Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study. Radiother Oncol. 2000;55(3):233–9.CrossRefGoogle Scholar
  10. 10.
    Milano MT et al. Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiat Oncol. 2008;3:36.CrossRefGoogle Scholar
  11. 11.
    Antonadou D et al. Randomized phase III trial of radiation treatment +/- amifostine in patients with advanced-stage lung cancer. Int J Radiat Oncol Biol Phys. 2001;51(4):915–22.CrossRefGoogle Scholar
  12. 12.
    Aapro M et al. MASCC/ESMO ANTIEMETIC GUIDELINE 2016. http://www.mascc.org/antiemetic-guidelines.
  13. 13.
    Levin VA et al. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys. 2011;79(5):1487–95.CrossRefGoogle Scholar
  14. 14.
    Kirste S et al. Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial. Cancer. 2011;117(16):3788–95.CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.RecklinghausenDeutschland
  2. 2.

Personalised recommendations